These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 35367207)

  • 1. Endothelial expression of human amyloid precursor protein leads to amyloid β in the blood and induces cerebral amyloid angiopathy in knock-in mice.
    Tachida Y; Miura S; Muto Y; Takuwa H; Sahara N; Shindo A; Matsuba Y; Saito T; Taniguchi N; Kawaguchi Y; Tomimoto H; Saido T; Kitazume S
    J Biol Chem; 2022 Jun; 298(6):101880. PubMed ID: 35367207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
    Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
    Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. House dust mite-induced asthma exacerbates Alzheimer's disease changes in the brain of the App
    Sahu B; Nookala S; Floden AM; Ambhore NS; Sathish V; Klug MG; Combs CK
    Brain Behav Immun; 2024 Oct; 121():365-383. PubMed ID: 39084541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.
    Kasri A; Camporesi E; Gkanatsiou E; Boluda S; Brinkmalm G; Stimmer L; Ge J; Hanrieder J; Villain N; Duyckaerts C; Vermeiren Y; Pape SE; Nicolas G; Laquerrière A; De Deyn PP; Wallon D; Blennow K; Strydom A; Zetterberg H; Potier MC
    Acta Neuropathol; 2024 Jul; 148(1):8. PubMed ID: 39026031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.
    Kulic L; McAfoose J; Welt T; Tackenberg C; Späni C; Wirth F; Finder V; Konietzko U; Giese M; Eckert A; Noriaki K; Shimizu T; Murakami K; Irie K; Rasool S; Glabe C; Hock C; Nitsch RM
    Transl Psychiatry; 2012 Nov; 2(11):e183. PubMed ID: 23149447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models.
    Kumar-Singh S
    Int J Mol Sci; 2009 Apr; 10(4):1872-1895. PubMed ID: 19468344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.
    Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GalNAc glycosylation determines intracellular trafficking of APP and Aβ production.
    Tachida Y; Iijima J; Takahashi K; Suzuki H; Kizuka Y; Yamaguchi Y; Tanaka K; Nakano M; Takakura D; Kawasaki N; Saito Y; Manya H; Endo T; Kitazume S
    J Biol Chem; 2023 Jul; 299(7):104905. PubMed ID: 37302553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain endothelial cells produce amyloid {beta} from amyloid precursor protein 770 and preferentially secrete the O-glycosylated form.
    Kitazume S; Tachida Y; Kato M; Yamaguchi Y; Honda T; Hashimoto Y; Wada Y; Saito T; Iwata N; Saido T; Taniguchi N
    J Biol Chem; 2010 Dec; 285(51):40097-103. PubMed ID: 20952385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-life stress induces the development of Alzheimer's disease pathology via angiopathy.
    Tanaka T; Hirai S; Hosokawa M; Saito T; Sakuma H; Saido T; Hasegawa M; Okado H
    Exp Neurol; 2021 Mar; 337():113552. PubMed ID: 33309748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
    Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
    Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.
    Han BH; Zhou ML; Abousaleh F; Brendza RP; Dietrich HH; Koenigsknecht-Talboo J; Cirrito JR; Milner E; Holtzman DM; Zipfel GJ
    J Neurosci; 2008 Dec; 28(50):13542-50. PubMed ID: 19074028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cerebral amyloid angiopathy on the brain vasculome.
    Deng W; Guo S; van Veluw SJ; Yu Z; Chan SJ; Takase H; Arai K; Ning M; Greenberg SM; Lo EH; Bacskai BJ
    Aging Cell; 2022 Aug; 21(8):e13503. PubMed ID: 35851991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.
    Zandl-Lang M; Fanaee-Danesh E; Sun Y; Albrecher NM; Gali CC; Čančar I; Kober A; Tam-Amersdorfer C; Stracke A; Storck SM; Saeed A; Stefulj J; Pietrzik CU; Wilson MR; Björkhem I; Panzenboeck U
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):40-60. PubMed ID: 28941799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.